Epistem Pharmacogenomics is part of Epistem Ltd, a division of genedrive plc and is headquartered in Manchester in the UK.
Working with Epistem Pharmacogenomics
We offer both contractual fee for service models as well as collaborative partnership programs for biomarker and target discovery. We also have extensive experience in validating and developing companion diagnostic assays. Together with pharmaceutical companies we enable companion diagnostic product development and regulatory submission.
Epistem Pharmacogenomics provides biomarker and personalised medicine Information to pharmaceutical and biotechnology companies from very limited quantities of RNA. We specialise in advancing drug development programs for oncology, inflammatory and fibrotic disease indications through our innovative plucked hair analysis and laser capture microdissection techniques as well as offering GCLP accredited laboratory gene expression and DNA genotyping services.
Epistem Pharmacogenomics high level of expertise and customer focus has led to an enviable track record and impressive repeat business ratio. We have worked with over 200 pharmaceutical and biotechnology companies supporting clinical trials and have developed long term collaborative relationships with several market leaders.
Epistem's pharmacogenomics laboratories are GCLP accredited. GCLP is a set of widely adopted guidelines for the quality system applied to organisations that carry out analysis of clinical samples. Our international standard (ISO 13485) certification is for design, development, manufacture and distribution of molecular diagnostic instruments and molecular IVD assays.